Abstract Title:

Efficacy of ethyl-EPA as a treatment for Huntington disease: A systematic review and meta-analysis.

Abstract Source:

Acta Neuropsychiatr. 2019 Mar 20:1-38. Epub 2019 Mar 20. PMID: 30890195

Abstract Author(s):

Sara Morsy, Samar Morsy Khalil, Mohamed Fahmy Doheim, Mohamed Gomaa Kamel, Doaa Saeed Mahmoud El-Basiony, Hossam Idrees Ahmed Hassan, Ahmed Abdelaziz Eisa, Cao Thị Anh Ngoc, Nguyen Phu Dang, Kenji Hirayama, Nguyen Tien Huy

Article Affiliation:

Sara Morsy


OBJECTIVE: After MRI studies suggested the efficacy of ethyl-EPA in reducing the progressive brain atrophy in Huntington disease, trials were conducted to test its efficacy as a treatment for Huntington disease. Trials continued for six months did not find any significant improvement urging discontinuation of the drug. However, trials continued for 12 months indicated improvement of motor functions in these patients.

METHODS: We searched 12 electronic databases to find randomized clinical trials relevant to our inclusion criteria. After screening, only five papers were included. Continuous and binary variables were analyzed to compute the pooled mean difference (MD) and risk ratio (RR), respectively. Quality effect model meta-analysis was used as a post hoc analysis for studies at 12 months.FindingsMeta-analysis indicated that ethyl-eicosapentaenoic acid has no significant effect on any scale of HD at six months. At 12 months, two studies suggested significant improvements of the total motor score and total motor score -4 in both fixed and quality effect model [MD = -2.720, 95% CI (-4.76; -.68), P = 0.009], [MD = -2.225, 95% CI (-3.842; -0.607), P = 0.007] respectively. maximal chorea score showed significant results [MD = -1.013, 95% CI (-1.793; -0.233), P = 0.011] in only fixed effect model, while no improvement was detected for Stroop color naming test or symbol digit modality.

CONCLUSION: Meta-analysis indicated a significant improvement of motor scores only after 12 months. These results should be interpreted cautiously because only two studies had assessed the efficacy of ethyl-EPA after 12 months with one of them having six months open-label phase.

Study Type : Meta Analysis, Review

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.